158 related articles for article (PubMed ID: 34415143)
1. Rational Design, Pharmacomodulation, and Synthesis of [
Lin JJ; Chuang CP; Lin JY; Huang FT; Huang CW
ACS Sens; 2021 Sep; 6(9):3424-3435. PubMed ID: 34415143
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z
Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
[TBL] [Abstract][Full Text] [Related]
4. [
Hu K; Wang L; Wu H; Huang S; Tian Y; Wang Q; Xiao C; Han Y; Tang G
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2833-2843. PubMed ID: 34893920
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of
Zhao L; Niu B; Fang J; Pang Y; Li S; Xie C; Sun L; Zhang X; Guo Z; Lin Q; Chen H
J Nucl Med; 2022 Jun; 63(6):862-868. PubMed ID: 34556528
[TBL] [Abstract][Full Text] [Related]
6.
Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
[TBL] [Abstract][Full Text] [Related]
7. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
[TBL] [Abstract][Full Text] [Related]
8. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
9.
Kratochwil C; Flechsig P; Lindner T; Abderrahim L; Altmann A; Mier W; Adeberg S; Rathke H; Röhrich M; Winter H; Plinkert PK; Marme F; Lang M; Kauczor HU; Jäger D; Debus J; Haberkorn U; Giesel FL
J Nucl Med; 2019 Jun; 60(6):801-805. PubMed ID: 30954939
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [
Zang J; Wen X; Lin R; Zeng X; Wang C; Shi M; Zeng X; Zhang J; Wu X; Zhang X; Miao W; Xu P; Guo Z; Zhang J; Chen X
Theranostics; 2022; 12(16):7180-7190. PubMed ID: 36276644
[TBL] [Abstract][Full Text] [Related]
11. Improved cancer detection in Waldeyer's tonsillar ring by
Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and preclinical evaluation of novel
Zhou H; Zhong J; Peng S; Liu Y; Tang P; Cai Z; Wang L; Xu H; Hu K
Eur J Med Chem; 2024 Jan; 264():115993. PubMed ID: 38039792
[TBL] [Abstract][Full Text] [Related]
13. Impact of
Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of
Bendre S; Zhang Z; Colpo N; Zeisler J; Wong AAWL; Bénard F; Lin KS
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110717
[TBL] [Abstract][Full Text] [Related]
15. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.
Lindner T; Loktev A; Altmann A; Giesel F; Kratochwil C; Debus J; Jäger D; Mier W; Haberkorn U
J Nucl Med; 2018 Sep; 59(9):1415-1422. PubMed ID: 29626119
[TBL] [Abstract][Full Text] [Related]
16. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
[TBL] [Abstract][Full Text] [Related]
17. Value of [
Zhou Y; Yang X; Liu H; Luo W; Liu H; Lv T; Wang J; Qin J; Ou S; Chen Y
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3493-3501. PubMed ID: 33829416
[TBL] [Abstract][Full Text] [Related]
18. Rational Design and Pharmacomodulation of Protein-Binding Theranostic Radioligands for Targeting the Fibroblast Activation Protein.
Meng L; Fang J; Zhao L; Wang T; Yuan P; Zhao Z; Zhuang R; Lin Q; Chen H; Chen X; Zhang X; Guo Z
J Med Chem; 2022 Jun; 65(12):8245-8257. PubMed ID: 35658448
[TBL] [Abstract][Full Text] [Related]
19. Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy.
Xu M; Zhang P; Ding J; Chen J; Huo L; Liu Z
J Nucl Med; 2022 Jun; 63(6):952-958. PubMed ID: 34593598
[TBL] [Abstract][Full Text] [Related]
20. [
Rosenkrans ZT; Massey CF; Bernau K; Ferreira CA; Jeffery JJ; Schulte JJ; Moore M; Valla F; Batterton JM; Drake CR; McMillan AB; Sandbo N; Pirasteh A; Hernandez R
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3705-3716. PubMed ID: 35556159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]